Literature DB >> 10318877

Characterization of the DOC1/APC10 subunit of the yeast and the human anaphase-promoting complex.

R Grossberger1, C Gieffers, W Zachariae, A V Podtelejnikov, A Schleiffer, K Nasmyth, M Mann, J M Peters.   

Abstract

The anaphase-promoting complex/cyclosome (APC) is a ubiquitin-protein ligase whose activity is essential for progression through mitosis. The vertebrate APC is thought to be composed of 8 subunits, whereas in budding yeast several additional APC-associated proteins have been identified, including a 33-kDa protein called Doc1 or Apc10. Here, we show that Doc1/Apc10 is a subunit of the yeast APC throughout the cell cycle. Mutation of Doc1/Apc10 inactivates the APC without destabilizing the complex. An ortholog of Doc1/Apc10, which we call APC10, is associated with the APC in different vertebrates, including humans and frogs. Biochemical fractionation experiments and mass spectrometric analysis of a component of the purified human APC show that APC10 is a genuine APC subunit whose cellular levels or association with the APC are not cell cycle-regulated. We have further identified an APC10 homology region, which we propose to call the DOC domain, in several protein sequences that also contain either cullin or HECT domains. Cullins are present in several ubiquitination complexes including the APC, whereas HECT domains represent the catalytic core of a different type of ubiquitin-protein ligase. DOC domains may therefore be important for reactions catalyzed by several types of ubiquitin-protein ligases.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10318877     DOI: 10.1074/jbc.274.20.14500

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Mitotic regulation of the APC activator proteins CDC20 and CDH1.

Authors:  E R Kramer; N Scheuringer; A V Podtelejnikov; M Mann; J M Peters
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  The RING-H2 finger protein APC11 and the E2 enzyme UBC4 are sufficient to ubiquitinate substrates of the anaphase-promoting complex.

Authors:  M Gmachl; C Gieffers; A V Podtelejnikov; M Mann; J M Peters
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 3.  Structural insights into anaphase-promoting complex function and mechanism.

Authors:  David Barford
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-12-27       Impact factor: 6.237

4.  Sequence characterization and promoter identification of porcine APC10 gene.

Authors:  W B He; Z W Wang; Y Li; Z L Tang; S L Yang; Y L Mu; K M Peng; K Li
Journal:  Mol Biol Rep       Date:  2010-03-16       Impact factor: 2.316

Review 5.  Inhibition of NEDD8-conjugation pathway by novel molecules: potential approaches to anticancer therapy.

Authors:  Tomoaki Tanaka; Tatsuya Nakatani; Tetsu Kamitani
Journal:  Mol Oncol       Date:  2012-01-21       Impact factor: 6.603

6.  Oligosyndactylism mice have an inversion of chromosome 8.

Authors:  Thomas L Wise; Dimitrina D Pravtcheva
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

7.  Dimerization of CUL7 and PARC is not required for all CUL7 functions and mouse development.

Authors:  Jeffrey R Skaar; Takehiro Arai; James A DeCaprio
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

8.  Mammalian resistance to oxidative stress: a comparative analysis.

Authors:  Toshihide Suzuki; Douglas R Spitz; Purvee Gandhi; H Y Lin; Dana R Crawford
Journal:  Gene Expr       Date:  2002

9.  PAM mediates sustained inhibition of cAMP signaling by sphingosine-1-phosphate.

Authors:  Sandra C Pierre; Julia Häusler; Kerstin Birod; Gerd Geisslinger; Klaus Scholich
Journal:  EMBO J       Date:  2004-07-15       Impact factor: 11.598

10.  Doc1 mediates the activity of the anaphase-promoting complex by contributing to substrate recognition.

Authors:  Lori A Passmore; Elizabeth A McCormack; Shannon W N Au; Angela Paul; Keith R Willison; J Wade Harper; David Barford
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.